real world tirzepatide study outcomes
Prescription Weight Loss Semaglutide Is Overrated - Tirzepatide Prevails
In a 12-month registry of 3,200 adults, tirzepatide achieved an average 15.4% weight loss, clearly outpacing semaglutide’s typical 12% reduction. This suggests the newer agent is not just marginally better but substantially more effective for most patients. Medical Disclaimer: This article is for informational purposes only and